Kalman Magyar - Publications

Affiliations: 
Semmelweis Egyetem, Hungary 
Area:
Pharmacology, Psychobiology Psychology

42 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Szökő É, Tábi T, Riederer P, Vécsei L, Magyar K. Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 29417334 DOI: 10.1007/S00702-018-1853-9  0.315
2015 Huleatt PB, Khoo ML, Chua YY, Tan TW, Liew RS, Balogh B, Deme R, Gölöncsér F, Magyar K, Sheela DP, Ho HK, Sperlágh B, Mátyus P, Chai CL. Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson's disease. Journal of Medicinal Chemistry. 58: 1400-19. PMID 25627172 DOI: 10.1021/Jm501722S  0.312
2012 Lajkó E, Polgár L, Láng O, Lengyel J, K?hidai L, Magyar K. Basic cell physiological activities (cell adhesion, chemotaxis and proliferation) induced by selegiline and its derivatives in Mono Mac 6 human monocytes. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 545-56. PMID 22086140 DOI: 10.1007/S00702-011-0735-1  0.345
2011 Magyar K. The pharmacology of selegiline. International Review of Neurobiology. 100: 65-84. PMID 21971003 DOI: 10.1016/B978-0-12-386467-3.00004-2  0.371
2010 Magyar K, Szende B, Jenei V, Tábi T, Pálfi M, Szöko E. R-deprenyl: pharmacological spectrum of its activity. Neurochemical Research. 35: 1922-32. PMID 20725780 DOI: 10.1007/S11064-010-0238-8  0.725
2010 Szende B, Barna G, Magyar K. Cytoprotective effect of (-)-deprenyl, (-)desmethyl-deprenyl and (-)deprenyl-N-oxide on glutathione depleted A-2058 melanoma cells. Journal of Neural Transmission (Vienna, Austria : 1996). 117: 695-8. PMID 20454984 DOI: 10.1007/S00702-010-0413-8  0.346
2009 Szilágyi G, Simon L, Wappler E, Magyar K, Nagy Z. (-)Deprenyl-N-oxide, a (-)deprenyl metabolite, is cytoprotective after hypoxic injury in PC12 cells, or after transient brain ischemia in gerbils. Journal of the Neurological Sciences. 283: 182-6. PMID 19332347 DOI: 10.1016/J.Jns.2009.02.368  0.354
2008 Dunkel P, Gelain A, Barlocco D, Haider N, Gyires K, Sperlágh B, Magyar K, Maccioni E, Fadda A, Mátyus P. Semicarbazide-sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target. Current Medicinal Chemistry. 15: 1827-39. PMID 18691041 DOI: 10.2174/092986708785133022  0.334
2007 Magyar K, Szatmáry I, Szebeni G, Lengyel J. Pharmacokinetic studies of (-)-deprenyl and some of its metabolites in mouse. Journal of Neural Transmission. Supplementum. 165-73. PMID 17982891 DOI: 10.1007/978-3-211-73574-9_21  0.327
2007 Soltész Z, Tábi T, Halász AS, Pálfi M, Kocsis E, Magyar K, Tóth M, Szökö E. Studies on the insulinomimetic effects of benzylamine, exogenous substrate of semicarbazide-sensitive amine oxidase enzyme in streptozotocin induced diabetic rats. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 851-5. PMID 17431735 DOI: 10.1007/S00702-007-0700-1  0.747
2006 Magyar K, Pálfi M, Jenei V, Szöko E. Deprenyl: from chemical synthesis to neuroprotection. Journal of Neural Transmission. Supplementum. 143-56. PMID 17447425 DOI: 10.1007/978-3-211-33328-0_16  0.708
2006 Halász AS, Pálfi M, Tábi T, Magyar K, Szöko E. [Change of the nitric oxide synthase activity after administration of neurotoxic compounds in mice]. Acta Pharmaceutica Hungarica. 76: 33-6. PMID 17094674  0.759
2006 Somfai GM, Knippel B, Ruzicska E, Stadler K, Tóth M, Salacz G, Magyar K, Somogyi A. Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats. Neurochemistry International. 48: 746-52. PMID 16524643 DOI: 10.1016/J.Neuint.2005.12.009  0.316
2005 Jenei V, Zor K, Magyar K, Jakus J. [Role of R-(-)-deprenyl in adhesion of neuronal and non-neuronal cells]. Orvosi Hetilap. 146: 601-6. PMID 15856624  0.675
2005 Tábi T, Magyar K, Szöko E. Trace analysis of oxidized, nitrated, and chlorinated aromatic amino acids by capillary electrophoresis with electroosmotic flow modification allowing large-volume sample stacking. Electrophoresis. 26: 1940-7. PMID 15818575 DOI: 10.1002/Elps.200410289  0.312
2005 Jenei V, Zor K, Magyar K, Jakus J. Increased cell-cell adhesion, a novel effect of R-(-)-deprenyl. Journal of Neural Transmission (Vienna, Austria : 1996). 112: 1433-45. PMID 15785858 DOI: 10.1007/s00702-005-0295-3  0.68
2004 Szöko E, Tábi T, Halász AS, Pálfi M, Magyar K. High sensitivity analysis of nitrite and nitrate in biological samples by capillary zone electrophoresis with transient isotachophoretic sample stacking. Journal of Chromatography. A. 1051: 177-83. PMID 15532571 DOI: 10.1016/J.Chroma.2004.07.037  0.745
2004 Szöko E, Tábi T, Borbás T, Dalmadi B, Tihanyi K, Magyar K. Assessment of the N-oxidation of deprenyl, methamphetamine, and amphetamine enantiomers by chiral capillary electrophoresis: an in vitro metabolism study. Electrophoresis. 25: 2866-75. PMID 15352021 DOI: 10.1002/Elps.200406023  0.38
2004 Magyar K, Pálfi M, Tábi T, Kalász H, Szende B, Szöko E. Pharmacological aspects of (-)-deprenyl. Current Medicinal Chemistry. 11: 2017-31. PMID 15279565 DOI: 10.2174/0929867043364793  0.38
2004 Mátyus P, Dajka-Halász B, Földi A, Haider N, Barlocco D, Magyar K. Semicarbazide-sensitive amine oxidase: current status and perspectives. Current Medicinal Chemistry. 11: 1285-98. PMID 15134520 DOI: 10.2174/0929867043365305  0.347
2004 Tábi T, Halász AS, Pálfi M, Magyar K, Szöko E. Chiral separation of deprenyl-N-oxide isomers by capillary electrophoresis using various cyclodextrin derivatives. Journal of Chromatographic Science. 42: 21-6. PMID 14965411 DOI: 10.1093/Chromsci/42.1.21  0.728
2004 Pálfi M, Halász AS, Tábi T, Magyar K, Szöko E. Application of the measurement of oxidized pyridine dinucleotides with high-performance liquid chromatography-fluorescence detection to assay the uncoupled oxidation of NADPH by neuronal nitric oxide synthase. Analytical Biochemistry. 326: 69-77. PMID 14769337 DOI: 10.1016/J.Ab.2003.11.010  0.756
2004 Szöko É, Tábi T, Halász AS, Pálfi M, Kalász H, Magyar K. Chiral characterization and quantification of deprenyl-N-oxide and other deprenyl metabolites in rat urine by capillary electrophoresis Chromatographia. 60. DOI: 10.1365/S10337-004-0301-1  0.758
2003 Magyar K, Mészáros Z. Semicarbazide-sensitive amine oxidase (SSAO): present and future. Inflammopharmacology. 11: 165-73. PMID 15035818 DOI: 10.1163/156856003765764335  0.341
2003 Tábi T, Magyar K, Szöko E. Chiral characterization of deprenyl-N-oxide and other deprenyl metabolites by capillary electrophoresis using a dual cyclodextrin system in rat urine. Electrophoresis. 24: 2665-73. PMID 12900880 DOI: 10.1002/Elps.200305468  0.355
2002 Haberle D, Magyar K, Szöko E. Determination of the norepinephrine level by high-performance liquid chromatography to assess the protective effect of MAO-B inhibitors against DSP-4 toxicity. Journal of Chromatographic Science. 40: 495-9. PMID 12433110 DOI: 10.1093/Chromsci/40.9.495  0.36
2002 Karádi I, Mészáros Z, Csányi A, Szombathy T, Hosszúfalusi N, Romics L, Magyar K. Serum semicarbazide-sensitive amine oxidase (SSAO) activity is an independent marker of carotid atherosclerosis. Clinica Chimica Acta; International Journal of Clinical Chemistry. 323: 139-46. PMID 12135815 DOI: 10.1016/S0009-8981(02)00189-4  0.311
2002 Haberle D, Szökõ E, Magyar K. The influence of metabolism on the MAO-B inhibitory potency of selegiline. Current Medicinal Chemistry. 9: 47-51. PMID 11860347 DOI: 10.2174/0929867023371481  0.336
2001 Haberle D, Szökö E, Halász AS, Magyar K. The effect of low oral doses of (-)-deprenyl and its metabolites on DSP-4 toxicity. Journal of Neural Transmission (Vienna, Austria : 1996). 108: 1239-47. PMID 11768624 DOI: 10.1007/S007020100002  0.741
2001 Szökõ E, Haberle D, Halász AS, Tekes K, Magyar K. Protective effect of 7-nitroindazole against DSP-4 induced noradrenaline depletion in mouse hippocampus. Journal of Neural Transmission (Vienna, Austria : 1996). 108: 407-13. PMID 11475008 DOI: 10.1007/S007020170062  0.767
2001 Szende B, Bökönyi G, Bocsi J, Kéri G, Timár F, Magyar K. Anti-apoptotic and apoptotic action of (-)-deprenyl and its metabolites. Journal of Neural Transmission (Vienna, Austria : 1996). 108: 25-33. PMID 11261744 DOI: 10.1007/S007020170094  0.305
2001 Magyar K, Mészáros Z, Mátyus P. Semicarbazide-sensitive amine oxidase. Its physiological significance Pure and Applied Chemistry. 73: 1393-1400. DOI: 10.1351/Pac200173091393  0.365
1998 Rácz D, Zillikens S, Forstreuter P, Nagykáldi Z, Magyar K, Török TL. Pre-junctional stimulatory and post-junctional inhibitory effects of pinacidil in the isolated main pulmonary artery of the rabbit under different experimental conditions. Pulmonary Pharmacology & Therapeutics. 10: 199-209. PMID 9695143 DOI: 10.1006/Pupt.1997.0092  0.311
1998 Magyar K, Szende B, Lengyel J, Tarczali J, Szatmáry I. The neuroprotective and neuronal rescue effects of (-)-deprenyl. Journal of Neural Transmission. Supplementum. 52: 109-23. PMID 9564614 DOI: 10.1007/978-3-7091-6499-0_13  0.377
1996 Magyar K, Szende B, Lengyel J, Tekes K. The pharmacology of B-type selective monoamine oxidase inhibitors; milestones in (-)-deprenyl research. Journal of Neural Transmission. Supplementum. 48: 29-43. PMID 8988460 DOI: 10.1007/978-3-7091-7494-4_4  0.356
1994 Magyar K. Behaviour of (-)-deprenyl and its analogues. Journal of Neural Transmission. Supplementum. 41: 167-75. PMID 7931223 DOI: 10.1007/978-3-7091-9324-2_23  0.357
1992 Cserháti T, Magyar K. Lipophilicity determination of some monoamine oxidase inhibitors: the effect of methanol and ammonium chloride. Journal of Chromatography. 575: 57-62. PMID 1517301 DOI: 10.1016/0378-4347(92)80503-I  0.306
1989 Török TL, Pauló T, Tóth PT, Azzidani AM, Powis DA, Magyar K. Sodium-azide-evoked noradrenaline and catecholamine release from peripheral sympathetic nerves and chromaffin cells. General Pharmacology. 20: 143-9. PMID 2541042 DOI: 10.1016/0306-3623(89)90006-2  0.302
1987 Hadházy P, Magyar K. Feedback control of arterial smooth muscle tone: the role of prostacyclin. British Journal of Pharmacology. 89: 861-3. PMID 3101929 DOI: 10.1111/J.1476-5381.1986.Tb11192.X  0.305
1986 Hadházy P, Nagy L, Dömötör L, Magyar K. Effects of indomethacin, prostaglandins E2 and I2 on the tone of human isolated femoral arteries. European Journal of Clinical Investigation. 16: 248-51. PMID 3089823 DOI: 10.1111/J.1365-2362.1986.Tb01337.X  0.305
1979 Ekstedt B, Magyar K, Knoll J. Does the B form selective monoamine oxidase inhibitor lose selectivity by long term treatment? Biochemical Pharmacology. 28: 919-23. PMID 454488 DOI: 10.1016/0006-2952(79)90376-9  0.351
1978 Knoll J, Ecsery Z, Magyar K, Sátory E. Novel (-)deprenyl-derived selective inhibitors of B-type monoamine oxidase. The relation of structure to their action. Biochemical Pharmacology. 27: 1739-47. PMID 708454 DOI: 10.1016/0006-2952(78)90550-6  0.301
Show low-probability matches.